Pharma brands spent $3.9B on TV ads in 2021, led by Sanofi, Regeneron’s Dupixent and Novo Nordisk’s Rybelsus
Third-place is unfamiliar territory for AbbVie’s blockbuster drug Humira – even when it comes to TV ad spending. But that’s where the drug ended up in 2021 after AbbVie switched up Humira’s typically top-spend budget and reallocated some of its spending to newer sibling brands Rinvoq and Skyrizi.
The new No. 1 this year is Dupixent, Sanofi and Regeneron’s treatment approved in indications like asthma and eczema, according to data from realtime TV ad tracker iSpot.tv.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 144,300+ biopharma pros reading Endpoints daily — and it's free.